info@seagull-health.com
SeagullHealth
语言:
search
new
Channels for Purchasing Tibsovo® (Ivosidenib)
502
Article source: Seagull Pharmacy
Jan 07, 2026

Tibsovo® (Ivosidenib) is an oral targeted therapy indicated for IDH1 mutations. It has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of specific types of acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and cholangiocarcinoma.

Channels for Purchasing Tibsovo® (Ivosidenib)

Overseas Purchase

Patients may consult and purchase the medication at hospital pharmacies or licensed drugstores in countries/regions where Tibsovo® has been officially launched.

Given that drug prices may be affected by regional differences, exchange rate fluctuations and other factors, patients are advised to make a detailed budget and plan in advance before purchasing.

Purchase via Medical Service Providers

Patients may consult domestic overseas medical service agencies that have partnerships with international pharmacies or pharmaceutical manufacturers.

These agencies typically offer legitimate import channels, along with professional consultation and guidance services.

Precautions for Purchasing Tibsovo® (Ivosidenib)

Genetic Testing

Complete genetic testing: Confirm the IDH1 mutation status through a qualified testing institution.

Obtain a professional prescription: A prescription must be issued by a hematologist or oncologist based on the test results and clinical assessment of the patient’s condition. Purchasing prescription drugs without a valid prescription is illegal and dangerous.

Verify Drug Information and Source

Outer packaging inspection: Confirm the accuracy of details including the brand name (TIBSOVO), active ingredient (Ivosidenib), dosage strength (e.g., 250 mg), and manufacturer (Servier Pharmaceuticals LLC).

Batch number and expiration date check: Ensure these details are clearly printed and verifiable through relevant official systems.

How to Distinguish Authentic Tibsovo® (Ivosidenib) from Counterfeits

Inspect Packaging and Tablet Appearance

Packaging quality: Authentic products feature high-quality printing, clear coloration, and standard packaging materials. Be wary of products with shoddy packaging, typographical errors, or ambiguous information.

Tablet appearance: The 250 mg strength of Ivosidenib is a blue, oval, film-coated tablet, engraved with “IVO” on one side and “250” on the other.

Carefully compare the tablet’s color, shape, and engravings against the official descriptions.

Check Traceability Information

Batch number verification: Legitimate drugs are labeled with a unique batch number and expiration date on the outer packaging.

Verification can be conducted through official channels of the partner pharmacies of the service provider or the pharmaceutical manufacturer (assistance from the service provider may be required).

Regulatory code verification: Drugs in some countries/regions are affixed with an official regulatory code, which can be verified by scanning the code via designated official websites or mobile applications.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Ivosidenib(Tibsovo)
Ivosidenib(Tibsovo)
Adult patients with relapsed or refractory acute myeloid leukemia.
WeChat Scan
Free Inquiry
Recommended Articles
Adverse Reactions of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET kinase inhibitor that has become an important targeted therapy for the treatment of metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 ...
What Are the Precautions for Capmatinib (Tabrecta) Administration?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that offers a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutati...
Dosage and Administration, Recommended Dose of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is the world’s first approved targeted therapy for metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations. Rational administration of this medicat...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is an oral kinase inhibitor that received its first marketing approval in the United States in 2020. This medication is primarily indicated for the treatment of specific types of...
Dosage, Administration and Recommended Dose of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is the first targeted therapy indicated for acute myeloid leukemia (AML) with IDH1 mutations, and its standardized administration is crucial for treatment efficacy.Dosage, Adminis...
Channels for Purchasing Lorlatinib (Lorviqua)
Lorlatinib (Lorviqua) is a third-generation ALK inhibitor, offering an important treatment option for lung cancer patients. How to obtain the medication safely and in compliance with regulations, whil...
What Are the Indications for Lorlatinib (Lorviqua)?
Lorlatinib (Lorviqua) is an oral tyrosine kinase inhibitor primarily indicated for the treatment of specific types of non-small cell lung cancer (NSCLC). It provides a crucial therapeutic option for p...
What Are the Indications of Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important isocitrate dehydrogenase-1 (IDH1) inhibitor, providing an innovative treatment option for patients with various malignant tumors harboring IDH1 mutations.What Are ...
Related Articles
What Are the Indications of Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important isocitrate dehydrogenase-1 (IDH1) inhibitor, providing an innovative treatment option for patients with various malignant tumors harboring IDH1 mutations.What Are ...
Dosage, Administration and Recommended Dose of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is the first targeted therapy indicated for acute myeloid leukemia (AML) with IDH1 mutations, and its standardized administration is crucial for treatment efficacy.Dosage, Adminis...
Channels for Purchasing Tibsovo® (Ivosidenib)
Tibsovo® (Ivosidenib) is an oral targeted therapy indicated for IDH1 mutations. It has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of specific types of acute myeloid...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved